The majority of patients with relapsing light chain (AL) amyloidosis are not eligible for enrollment onto clinical trials: Using screen failures to define major unmet medical needs Meeting Abstract
| Authors: | Landau, H.; Comenzo, R. L.; Balasinorwala, T.; Warner, M.; Landgren, O.; Giralt, S. A.; Hassoun, H. |
| Abstract Title: | The majority of patients with relapsing light chain (AL) amyloidosis are not eligible for enrollment onto clinical trials: Using screen failures to define major unmet medical needs |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019005264 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.1786.1786 |
| Notes: | Meeting Abstract: 1786 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work